On August 5, 2022, the Board of Directors of Haemonetics Corporation appointed James C. D'Arecca, Executive Vice President, Chief Financial Officer, as the Company's principal accounting officer in connection with the previously reported departure of Dan Goldstein, Vice President, Corporate Controller, on or about August 9, 2022. Mr. D'Arecca also serves as the Company's principal financial officer.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
88.42 USD | +0.55% | +0.58% | +2.90% |
05-29 | Haemonetics Insider Sold Shares Worth $1,144,208, According to a Recent SEC Filing | MT |
05-29 | Haemonetics Insider Sold Shares Worth $775,253, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.90% | 4.47B | |
-7.02% | 180B | |
-0.25% | 109B | |
-2.81% | 68.93B | |
-5.34% | 46.41B | |
+12.46% | 45.43B | |
+7.38% | 43.26B | |
+16.17% | 30.05B | |
+16.10% | 25.19B | |
-7.63% | 23.34B |
- Stock Market
- Equities
- HAE Stock
- News Haemonetics Corporation
- Haemonetics Corporation Announces Management Changes